Prognostic Significance of Progesterone Receptor Immunohistochemistry in Endometrial Carcinoma

By Fukuda K.   Mori M.   Uchiyama M.   Iwai K.   Iwasaka T.   Sugimori H.  

Gynecologic Oncology, Vol. 69, Iss. 3, 1998-06 ,pp. : 220-225

Elsevier

Access to resources Recommend Favorite

Higher Expression of Receptor Tyrosine Kinase Axl, and Differential Expression of its Ligand, Gas6, Predict Poor Survival in Lung Adenocarcinoma Patients

By Ishikawa Masashi   Sonobe Makoto   Nakayama Ei   Kobayashi Masashi   Kikuchi Ryutaro   Kitamura Jiro   Imamura Naoto   Date Hiroshi  

Annals of Surgical Oncology, Vol. 20, Iss. 3, 2013-12 ,pp. : 467-476

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen and Progesterone Receptor Expression in Postmenopausal Tamoxifen-Exposed Endometrial Pathologies

By Cohen I.   Beyth Y.   Altaras M.M.   Shapira J.   Tepper R.   Cardoba M.   Yigael D.   Figer A.   Fishman A.   Berenhein J.  

Gynecologic Oncology, Vol. 67, Iss. 1, 1997-10 ,pp. : 8-15

Elsevier

Access to resources Recommend Favorite

Prognostic Significance of Progesterone Receptor Immunohistochemistry for Lymph Node Metastases in Endometrial Carcinoma

By Iwai K.   Fukuda K.   Hachisuga T.   Mori M.   Uchiyama M.   Iwasaka T.   Sugimori H.  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 351-359

Elsevier

Access to resources Recommend Favorite

Impact of metastatic estrogen receptor and progesterone receptor status on survival

By Lower Elyse  

Breast Cancer Research and Treatment, Vol. 90, Iss. 1, 2005-03 ,pp. : 65-70

Springer Publishing Company

Access to resources Recommend Favorite